Pharmaceutical R&D spending in European countries 2020

This statistic displays the European pharmaceutical industry's research and development expenditures by country in 2020 (or latest year available). The pharmaceutical industry in Denmark spent an estimated 1.49 billion euros on research and development in that year.

Pharmaceutical research and development spending in selected European countries in 2020 (in million euros)

Characteristic	R&D spending in million euros
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

2022

More information

Region

Europe

Survey time period

2020

Supplementary notes

EFPIA: European Federation of Pharmaceutical Industries and Associations
The figures relate to the R&D carried out in each country.
The figures are for 2020 or latest year available.
Austria, Slovenia: 2019; Bulgaria, France: 2017 data; Norway, Sweden: 2015 data; Cyprus, Ireland: 2013 data; Croatia, Netherlands: 2011 data.
Belgium, Croatia, Denmark, France, Germany, Greece, Ireland, Italy, Netherlands, Norway (LMI members), Poland, Romania, Slovenia, Sweden (LIF members), Switzerland (Interpharma members), Turkey: estimate.

Citation formats